Indeed, despite comparable anti-THSD7A titers, C3−/− mice, which showed an interruption of the complement cascade at the level of C3, developed lower overall proteinuria, less hypoalbuminemia, less hyperlipidemia, and less pronounced podocyte foot process effacement than WT littermate controls. The gene discussed is C3; the disease is Hypoalbuminemia.